Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Expert Opinion on Pharmacotherapy|November 15, 2024
"Shifting sands in cystic fibrosis": impacts of CFTR modulators on reproductive health in people with cystic fibrosis and challenges related to in utero exposureImogen Felton, Amy Downes, Idan Bokobza, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 25, 2026
High incidence of gestational diabetes mellitus in females with CF persists in the triple CFTR modulator era: implications for screeningAmy Downes, Ladina Weitnauer, Sarah Collins, et al.BMJ Open Respiratory Research|June 30, 2026
Maternal, Infant, Reproductive and Child Health in Cystic Fibrosis (MATRIARCH_CF): a prospective, observational study to evaluate pregnancy and parenthood in females with cystic fibrosis and health of the offspring in the CFTR-modulator eraAmy Downes, Idan Bokobza, Ladina Weitnauer, et al.BJOG : an International Journal of Obstetrics and Gynaecology|November 10, 2025
Obstetric and Neonatal Outcomes in Pregnancies From a Dedicated Cystic Fibrosis-Maternal Health Service: A Retrospective StudyRebecca Scott, Amy Downes, Ladina Weitnauer, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 28, 2026
International Delphi consensus recommendations for the follow-up of children born to people with CF and exposed to CFTR modulators in utero or through breastfeeding; endorsed by the European Cystic Fibrosis SocietyIdan Bokobza, Traci M Kazmerski, Louise Thomson, et al.Pageof 1